RUBY BUSH: Open Payments
NPI 1598398018 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,705 in 99 payments from 17 companies in 2025. Trend: 2023 $5,358 · 2024 $2,673 · 2025 $3,705
Food & beverage: $3,617Education: $88
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $860 |
| Janssen Biotech, Inc. | 13 | $474 |
| ABBVIE INC. | 19 | $380 |
| GENZYME CORPORATION | 9 | $372 |
| UCB, Inc. | 6 | $360 |
| Arcutis Biotherapeutics, Inc. | 8 | $337 |
| Regeneron Healthcare Solutions, Inc. | 10 | $305 |
| E.R. Squibb & Sons, L.L.C. | 5 | $163 |
| LEO Pharma Inc. | 4 | $109 |
| PFIZER INC. | 5 | $103 |
Products named: ILUMYA, DUPIXENT, TREMFYA, Bimzelx, Zoryve, RINVOQ, SKYRIZI, Sotyktu.
Industry payments across FL — which companies pay providers there.
